These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 20944103)

  • 1. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities.
    Valdez CN; Sánchez-Zuno GA; Bucala R; Tran TT
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
    Kindt N; Descamps G; Lechien JR; Remmelink M; Colet JM; Wattiez R; Berchem G; Journe F; Saussez S
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30634708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
    Wang SS; Cen X; Liang XH; Tang YL
    Oncotarget; 2017 Feb; 8(6):10650-10661. PubMed ID: 27788497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.
    Kindt N; Journe F; Laurent G; Saussez S
    Oncol Lett; 2016 Oct; 12(4):2247-2253. PubMed ID: 27698786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
    Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
    Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CD74 in head and neck squamous cell carcinomas.
    Kindt N; Lechien JR; Nonclercq D; Laurent G; Saussez S
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):937-47. PubMed ID: 24663824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
    Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
    Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
    Kindt N; Preillon J; Kaltner H; Gabius HJ; Chevalier D; Rodriguez A; Johnson BD; Megalizzi V; Decaestecker C; Laurent G; Saussez S
    J Cancer Res Clin Oncol; 2013 May; 139(5):727-37. PubMed ID: 23354841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
    Schulz R; Marchenko ND; Holembowski L; Fingerle-Rowson G; Pesic M; Zender L; Dobbelstein M; Moll UM
    J Exp Med; 2012 Feb; 209(2):275-89. PubMed ID: 22271573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
    Tomiyasu M; Yoshino I; Suemitsu R; Okamoto T; Sugimachi K
    Clin Cancer Res; 2002 Dec; 8(12):3755-60. PubMed ID: 12473586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Hira E; Ono T; Dhar DK; El-Assal ON; Hishikawa Y; Yamanoi A; Nagasue N
    Cancer; 2005 Feb; 103(3):588-98. PubMed ID: 15612021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
    Cludts S; Decaestecker C; Johnson B; Lechien J; Leroy X; Kindt N; Kaltner H; André S; Gabius HJ; Saussez S
    Anticancer Res; 2010 Sep; 30(9):3313-9. PubMed ID: 20944103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 upregulation during tumor progression in head and neck cancer.
    Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
    Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
    Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
    Xia HH; Zhang ST; Lam SK; Lin MC; Kung HF; Wong BC
    Carcinogenesis; 2005 Jan; 26(1):11-5. PubMed ID: 15358635
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.